Iatrogenic Cushing’s Syndrome with Secondary Adrenal Suppression Misdiagnosed as Protease Inhibitor-Induced Lipodystrophy in an HIV Positive Patient: Case Report
Journal Title: Haematology International Journal - Year 2017, Vol 1, Issue 2
Abstract
1.1. Background: Ritonavir is a commonly prescribed protease inhibitor (PI) which is used in low doses to boost levels of other protease inhibitors pharmacokinetically. It is a potent inhibitor of hepatic cytochrome P450 3A4 (CYP3A4) isoenzyme and reduces the metabolism of systemic steroids leading to clinical Cushing's syndrome and secondary adrenal insufficiency. Despite occasional reports of Cushing's syndrome occurring with the use of injectable triamcinolone, even in the absence of CYP3A4 inhibition, it is unclear if caution should be exercised when considering local steroid injections in the setting of ritonavir therapy. We herein report the case of an iatrogenic steroid induced Cushing’s syndrome due to triamcinolone-ritonavir interaction misdiagnosed as PI induced lipodystrophy. 1.2. Case Presentation: We present the case of a 47-year-old HIV positive African male patient, who was switched from Tenofovir/ Lamivudine/ Efavirenz combination therapy to Abacavir/ Lamivudine/ Atazanavir/ Ritonavir due to virologic failure and had been on this new regimen for 1 year. He had been on over-the-counter intramuscular triamcinolone for 3 months, for knee pain and presented with a 2-month history of weight gain, swollen face and distended abdomen. Clinical examination revealed a moon face, dorsocervical hump, central obesity, fair skin, and pitting edema. He was initially thought to have PI induced lipodystrophy but after thorough examination and laboratory investigations, a diagnosis of iatrogenic Cushing syndrome with adrenal suppression was made and he was managed with hydrocortisone replacement therapy with marked regression of symptoms thereafter. 1.3. Conclusion: Cushing’s syndrome should be considered as an important differential in HIV positive patients on PI who develop abnormal fat deposition, especially in the context of steroid use. A high index of suspicion is required for early diagnosis and management. Whenever possible, the use of glucocorticoid therapy through any route should be avoided in patients on ritonavir-boosted protease inhibitor therapy.
Authors and Affiliations
Derrick Tembi Efie
Keywords
Related Articles
- EP ID EP291042
- DOI -
- Views 105
- Downloads 0
Knowledge, Perception and Opinion of Health Workers on Bone Marrow Transplantation in Nigeria
1.1. Background: Bone marrow transplantation (BMT) or haematopoietic stem cell transplantation (HSCT) is a procedure used to cure haematopoietic malignancies, poorly functioning haematopoietic or immune system and geneti...
Transfusion Support and Red Cell Alloimmunisation in Thalassemia Patients
Thalassemias are the most common mono genetic disease worldwide. It has high frequency extending from the Mediterranean basin through the Middle East (Iran), India and Southeast Asia. In India, the carrier rate of Beta T...
Multiple Myeloma in Cameroon: Clinico-Biological Characteristics of Patients; an Experience from Douala General Hospital
1.1. Background: Multiple myeloma is the most common haematological malignancy among blacks. There is paucity of data on this subject in Africa in general and Cameroon in Cameroon. This study aims at describing initial c...
Peripheral T Cell Lymphoma with Follicular Helper Phenotype, Case Report and Literature Review
T-cell lymphomas are a heterogeneous group of lymphoid neoplasms, with a broad classification; in which the peripheral T-cell lymphoma not otherwise specified, is the most frequently diagnosed subtype, demonstrating the...
Ferritin Level in Pre and Postmenopausal Women Attending Usmanu Danfodiyo University Teaching Hospital Sokoto
Healthy individuals possess 3-4g of iron in his/her iron store, mostly in haemoglobin (oxygen-carrying pigment of blood) which is the most essential requirement of blood. Ferritin is a ubiquitous intracellular protein th...